Overview
Financials
Revenue history (in k)
Filing timeliness
1 of 3 financial statements was filed late (for 2024, 307 days late).
- 202518/05/2026
- 202418/05/2026
- 202312/07/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- FISH probes
- DNA probes
- FISH testing accessories
- FISH testing equipment
- Molecular diagnostics consulting
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Elementor
Public procurement
10 tenders recorded as contractor: 2 national ($146,129) and 8 EU ($771,463).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Apr 7, 2026 | Supply of reagents for 24 months for Przykliniczne Laboratorium Hematologiczne – area II | $13,585$13,585 | Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wrocławiu | |
| Dec 10, 2025 | Open tender procedure for the award of a public contract for the supply of reagents for the Genetic Diagnostics Department for bone tumour diagnostics | $5,517$5,517 | Uniwersytecki Szpital Dziecięcy w Lublinie | |
| Oct 15, 2025 | Servicing of medical and laboratory equipment | $4,957$4,957 | Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy |
Trademarks
Dreamgene holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2024.
| Mark | Protected until | |
|---|---|---|
| DreamGene | Jul 11, 2034 |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Leszek Czerskiage 56 | 10 | $135.06 | 10% |
Tomasz Marek Czerskiage 54 | 90 | $1,215.56 | 90% |
Tomasz Marek Czerski and Andrzej Leszek Czerski hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-10-19.
97 1030 0019 0109 8503 0020 5913
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 440.6KPLN 440,581 |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o. | $4,277,670.93 | cezal.lublin.pl | ||
| Bio-Novumsp. z o.o. | $3,459,663.10 | bio-novum.com | ||
| In2labsp. z o.o. | $1,446,943.64 | in2lab.pl | ||
| Interforum Pharmasp. z o.o. | $710,214.55 | interforumpharma.com | ||
| Mtree Medical Solutionssp. z o.o. | $705,822.77 | mtreemedical.com | ||
| Senocore sp. z o.o.sp. k. | $628,085.41 | senocore.com | ||
| Biotic Biomesp. z o.o. | $689,147.75 | bioticbiome.pl | ||
| Biogentech Polskasp. z o.o. | $685,703.63 | biogentech.pl | ||
| Sincofarmsp. z o.o. | $407,150.59 | sincofarm.pl | ||
| Myderm Laboratoriessp. z o.o. | $177,750.48 | myderm.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-11-08 | PKD change (Added: 9 codes) | |
| 2023-10-04 | Entered in the register |
FAQ
Last updated: 2026-05-18